Objective      To explore the curative effect of different treatments for cesarean scar pregnancy (CSP).       Methods      Clinical data of 260 CSP patients hospitalized in the gynecology department from January 2010 to December 2014 were collected and retrospectively analyzed. The patients were divided into group A (treated with methotrexate and gestational sac puncture

n=112)

group B (treated with methotrexate and uterine arterial embolization

n=82)

and group C (lesion resection of CSP via vagina

n=66). The success rate of treatment

serum β-HCG decline proportion after 1 week

period of HCG normalization

CSP mass disappearance time and hospital stay were observed after different treatments.       Results      Group B and group C were higher in the success rate of treatment than group A

and the difference was statistically significant (P0.05). In addition

it was found the serum β-HCG decline proportion was higher in group B and group C compared with group A (P0.05)

and the period of HCG normalization and the hospital stay were shorter (P0.05). In the other hand

the serum β-HCG decline proportion and the period of HCG normalization in group C were superior to those in group B

and the differences were statistically significant (P0.05). The hospital stay in group B was shorter than that in group C (P0.05).       Conclusion      Methotrexate combined with uterine arterial embolization exhibits higher success rate of treatment

reduces the hospital stay and the period of HCG normalization

and promotes the decline of serum β-HCG. So it is a safe and efficient method for treating CSP.